|
Blood Thinners Added to Clot-Busters Did Not Improve Stroke Outcomes
|
|
Animal studies raised some hopes that adding blood thinners to clot-busters could improve longer term outcomes in patients with severe strokes. That did not turn out to be the case, however, with a major clinical trial halted early. Find out what researchers found out about the early use of blood thinners in stroke emergencies and what other options still need to be studied.
|
|
|
ED Drugs Might Protect Against Alzheimer’s Disease
|
|
|
Phosphodiesterase type 5 inhibitors, initially developed as treatment for hypertension and angina, have found an extensive market as erectile dysfunction (ED) medications. A new study suggests that their benefits might extend even farther by protecting men against Alzheimer’s disease, especially for those individuals who are most frequently issued phosphodiesterase type 5 inhibitor prescriptions. Here are more details.
|
|
Billions Spent on “Decongestant” Now Considered Ineffective
|
|
|
Based on recommendations from an advisory committee suggesting that evidence does not show oral phenylephrine is an effective nasal decongestant, the FDA is considering taking formulations off the market. In a recent 11-year period, however, about $3.4 billion in pharmacy expenditures were spent on phenylephrine products. What will this mean for pharmacies? Read more.
|
|
|
For Neonatal Seizures
|
|
Now available for hospital formulary. Contact us to get the only FDA-approved treatment for neonatal seizures. Benzyl alcohol & preservative free. Read more.
|
|
.jpg)
